MONTE ROSA THERAPEUTICS INC (GLUE) — institutional ownership

204 funds reported holding MONTE ROSA THERAPEUTICS INC in their latest 13F filings, worth $2.32B in total (CUSIP 61225M102).

Largest holders

1. PRICE T ROWE ASSOCIATES INC /MD/ — $214M
2. NEA Management Company, LLC — $186M
3. BlackRock, Inc. (BLK) — $166M
4. TCG Crossover Management, LLC — $112M
5. Vestal Point Capital, LP — $111M
6. BVF INC/IL — $108M
7. BAKER BROS. ADVISORS LP — $105M
8. STATE STREET CORP (STT, STT-PG) — $90.3M
9. SUVRETTA CAPITAL MANAGEMENT, LLC — $85.9M
10. VANGUARD CAPITAL MANAGEMENT LLC — $82.6M

Famous investors holding it

• Stanley Druckenmiller portfolio (Duquesne Family Office)
• Ken Griffin portfolio (Citadel Advisors)
• D. E. Shaw portfolio (D. E. Shaw & Co.)
• Two Sigma portfolio (Two Sigma Investments)
• Renaissance Technologies portfolio (Renaissance Technologies)

Insider buying and selling at MONTE ROSA THERAPEUTICS INC

Who owns the most GLUE stock?

The largest institutional holders in the latest 13F filings are PRICE T ROWE ASSOCIATES INC /MD/ ($214M), NEA Management Company, LLC ($186M), BlackRock, Inc. (BLK) ($166M).

How many funds own GLUE?

204 funds reported holding it, worth $2.32B in total.